ArticleWorld journal of cardiology2021

Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis.

Wei-Jia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.